Andrew Cittadine
A general manager, CEO, and serial entrepreneur with a successful track record of identifying, founding, and building healthcare technology businesses from concept to commercialization to acquisition by Fortune Global 1000 firms. These include founding two successful imaging companies, Sensant (Siemens), a 3D ultrasound business, and American BioOptics, an optical imaging startup acquired by a leading global endoscopy company. Andrew was also the startup CEO for SonarMed (Medtronic). He has overseen the successful execution of multi-center clinical trials for new technologies and secured regulatory clearances for new technologies in Europe (CE) and the US (FDA). Andrew is a co-founder and board member of MATTER, the Midwest’s leading healthcare startup incubator, community nexus, and corporate innovation center. He also serves on the board of the Hadley Institute, a non-profit providing learning opportunities that empower adults with vision loss or blindness. Andrew earned a BS and MS in Electrical Engineering and a BA in History from Stanford University, and an MBA from Kellogg.
NUVention: Medical Innovation (HCAK-616-0)
NUvention Medical is designed to provide students with real-world experience as an innovator and entrepreneur in the rapidly evolving fields of health care devices and heath technology. Taught by a team of experienced healthcare entrepreneurs, innovators, and medical practitioners, the overall course goal is to develop an in-depth business plan, investor presentation, and viable product prototype for a new medical startup firm. To navigate the complex healthcare landscape, students form cross-disciplinary teams (including at least one student from Kellogg, Feinberg, McCormick, and Pritzker) to conceive of and identify an innovative new healthcare product and work to evaluate the opportunity with support from leading industry guest lecturers and direct mentoring from experience faculty advisors.
